Table 3 Predictors of HIV disease progression at multivariate analysis
From: Socio-economic determinants of disease progression among HIV infected adults in Kenya
Variable | Crude Odds Ratio (cOR) | 95 % CI | P value | Adjusted Odds Ratio (aOR) | 95 % CI | p value |
|---|---|---|---|---|---|---|
Gender | ||||||
Female | 0.6 | 0.3, 1.0 | 0.058 | 0.7 | 0.3, 1.5 | 0.354 |
Male | Ref | Ref | ||||
Age in years | 1.01 | 0.98, 1.04 | 0.600 | 0.99 | 0.95, 1.03 | 0.497 |
Expenditure/day | ||||||
< US$1 | 5.1 | 1.7, 15.1 | 0.003 | 4.5 | 1.4, 14.1 | 0.010 |
US$ 1-5 | 3.1 | 1.0, 9.4 | 0 .043 | 3.1 | 1.0, 9.7 | 0.057 |
>US$ 5 | Ref | Ref | ||||
Treatment group | ||||||
Acyclovir | 0.5 | 0.3, 0.9 | 0.013 | 0.6 | 0.3, 1.0 | 0.052 |
Placebo | Ref | Ref | ||||
CD4 at baseline/enrolment CD4 (cube root transformation) | 0.3 | 0.2, 0.4 | <0.0 | 0.3 | 0.2, 0.4 | <0.001 |